

Author: Pirotte Bernard Benoit Patricia Dogné Jean-Michel Masereel Bernard Rolin Stephanie Leval Xavier de
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.11, Iss.2, 2002-02, pp. : 275-281
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




The therapeutic potential of aromatase inhibitors
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. :




The therapeutic potential for phospholipase A2 inhibitors
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :